Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (64) clinical trials

A new nationwide clinical trial studying new psoriasis treatments for children is now enrolling. If you child has plaque psoriasis, he/she may be eligible to participate in a clinical study to help evaluate a potential new oral medication.  

Phase

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.  

Phase

The purpose of this research study is to compare the effectiveness and safety of the topical study drug Halobetasol Propionate Spray, 0.05% to Vehicle Spray, when applied to skin with plaque psoriasis.  

Phase N/A

This is a 52-week, randomized double-blind, placebo- and active comparator-controlled study for adults with stable moderate to severe plaque psoriasis. This study is testing the efficacy, safety, and durability response of BMS-986165 versus placebo and a currently available treatment for psoriasis. There are 18 office visits throughout the study and ...

Phase

This is a 24-week, randomized double-blind study for adults with moderate-to-severe plaque psoriasis. This study is comparing the efficacy and safety of ixekizumab to guselkumab. There are 15 office visits throughout the study and can include a physical exam, urine sampling, ECGs, blood draws, and assessments by qualified professionals and ...

Phase

Psoriasis is a chronic inflammatory disorder primarily affecting the skin and joints that occurs in diverse ethnic groups worldwide.  There is paucity of data on the use of topical medications in dark-skinned individuals. Unique issues in skin of color (SOC) populations, including increased risk of dyspigmentation (hyperpigmentation and hypopigmentation), make ...

Phase

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects with Moderate-to-Severe Plaque Psoriasis.  

Phase

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis.

Phase

A research study is evaluating an investigational medication for moderate to severe plaque psoriasis.

Phase N/A

The purpose of this study is to compare the efficacy and safety of ixekizumab to guselkumab in participants with moderate-to-severe plaque psoriasis.  

Phase